Clinical Trial Update: OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels

View source ↗

Summary

Clinical trial update for an adult heart transplant immunosuppression study guided by microRNA levels; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft Rejection
• Heart Failure

Snippet

Sponsor: Inova Health Care Services | Conditions: Cardiac Failure, Graft Rejection | Status: RECRUITING